Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/47848| Title: | Tofacitinib for juvenile idiopathic arthritis. | Authors: | Murray G.M.;Renton W.D. | Monash Health Department(s): | Paediatric - Rheumatology | Institution: | (Murray) Department of Rheumatology, Women's and Children's Hospital, Adelaide, SA 5006, Australia (Renton) Department of Paediatric Rheumatology, Monash Children's Hospital, Clayton, VIC, Australia |
Issue Date: | 17-May-2022 | Copyright year: | 2022 | Publisher: | Elsevier B.V. | Place of publication: | United Kingdom | Publication information: | The Lancet. 399(10338) (pp 1865-1866), 2022. Date of Publication: 14 May 2022. | Journal: | The Lancet | DOI: | http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1016/S0140-6736%2822%2900836-4 | PubMed URL: | 35569464 [https://www.ncbi.nlm.nih.gov/pubmed/?term=35569464] | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/47848 | Type: | Letter | Subjects: | juvenile rheumatoid arthritis tofacitinib |
Type of Clinical Study or Trial: | Opinion, perspective or news |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.